Last reviewed · How we verify
Investigational tetanus vaccine, adsorbed — Competitive Intelligence Brief
phase 3
Toxoid vaccine
Tetanus toxin (tetanospasmin)
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Investigational tetanus vaccine, adsorbed (Investigational tetanus vaccine, adsorbed) — Sinovac Life Sciences Co., Ltd.. An adsorbed tetanus toxoid vaccine that stimulates the immune system to produce antibodies against tetanus toxin, providing active immunization against tetanus infection.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Investigational tetanus vaccine, adsorbed TARGET | Investigational tetanus vaccine, adsorbed | Sinovac Life Sciences Co., Ltd. | phase 3 | Toxoid vaccine | Tetanus toxin (tetanospasmin) | |
| tetanus diphtheria toxoids vaccine | tetanus diphtheria toxoids vaccine | Biogen | marketed | Toxoid vaccine | ||
| Td alone | Td alone | Korea University Guro Hospital | marketed | Toxoid vaccine | Tetanus toxin and diphtheria toxin | |
| Tetanus and Diphtheria Toxoids Adsorbed | Tetanus and Diphtheria Toxoids Adsorbed | National Institute of Allergy and Infectious Diseases (NIAID) | marketed | Toxoid vaccine | ||
| Tetanus Toxoid Adsorbed Vaccine | Tetanus Toxoid Adsorbed Vaccine | Genentech, Inc. | marketed | Toxoid vaccine | Tetanus toxin (tetanospasmin) | |
| Tetanus Diphtheria Vaccine | Tetanus Diphtheria Vaccine | Nationwide Children's Hospital | marketed | Toxoid vaccine | ||
| Tetanus-diphteria | Tetanus-diphteria | Hospital Clinic of Barcelona | marketed | Toxoid vaccine | Tetanus toxin (tetanospasmin) and diphtheria toxin |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Toxoid vaccine class)
- GlaxoSmithKline · 2 drugs in this class
- Genentech, Inc. · 1 drug in this class
- Hoffmann-La Roche · 1 drug in this class
- Hospital Clinic of Barcelona · 1 drug in this class
- Korea University Guro Hospital · 1 drug in this class
- London School of Hygiene and Tropical Medicine · 1 drug in this class
- National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class
- Nationwide Children's Hospital · 1 drug in this class
- Sanofi Pasteur, a Sanofi Company · 1 drug in this class
- Sinovac Life Sciences Co., Ltd. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Investigational tetanus vaccine, adsorbed CI watch — RSS
- Investigational tetanus vaccine, adsorbed CI watch — Atom
- Investigational tetanus vaccine, adsorbed CI watch — JSON
- Investigational tetanus vaccine, adsorbed alone — RSS
- Whole Toxoid vaccine class — RSS
Cite this brief
Drug Landscape (2026). Investigational tetanus vaccine, adsorbed — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-tetanus-vaccine-adsorbed. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab